Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 18, 2016

Towards a random-access LC-MS/MS model for busulfan analysis

Roy W.A. Peake, Terence Law, Christopher L. Esposito and Mark D. Kellogg

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Jemal M. High-throughput quantitative bioanalysis by LC-MS/MS. Biomed Chromatogr 2002;14:422–9.Search in Google Scholar

2. Guilhaumou R, Lacarelle B, Sampol-Manos E. A rapid, simple and sensitive liquid chromatographytandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak immmunosuppressant kit. Methods Find Exp Clin Pharmacol 2010;32:737–43.Search in Google Scholar

3. Ji M, Kim S, Chung HJ, Lee W, Chun S, Min WK. Evaluation of the masstrak immunosuppressant XE kit for the determination of everolimus and cyclosporin A in human whole blood employing isotopically labeled internal standards. Clin Chem Lab Med 2011;49:2021–2027.Search in Google Scholar

4. Couchman L, Belsey SL, Handley SA, Flanagan RJ. A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration. Anal Bioanal Chem 2013;405:9455–66.Search in Google Scholar

5. Méresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L, et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992;10:135–41.Search in Google Scholar

6. Nath CE and Shaw PJ. Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring. Curr Clin Pharmacol 2007;2:75–91.Search in Google Scholar

7. Kellogg MD, Law T, Sakamoto M, Rifai N. Tandem mass spectrometry method for the quantification of serum busulfan. Ther Drug Monit 2005;27:625–9.Search in Google Scholar

8. dos Reis EO, Vianna-Jorge R, Suarez-Kurtz G, Lima EL, Azevedo Dde A. Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2005;19:1666–74.Search in Google Scholar

9. Moon, SY, Lim, MK, Hong S, Yeon, Y, Han M, Song SH, et al. Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry. Ann Lab Med 2014;34:7–14.Search in Google Scholar

10. Bunch DR, Heideloff C, Ritchie JC, Wang S. A fast and simple assay for busulfan in serum or plasma by liquid chromatography-tandem mass spectrometry using turbulent flow online extraction technology. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:3255–8.Search in Google Scholar

Received: 2016-8-13
Accepted: 2016-9-27
Published Online: 2016-10-18
Published in Print: 2017-6-27

©2017 Walter de Gruyter GmbH, Berlin/Boston